30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Bill Young

Track

Insider profile

Currently holds positions in NanoString Technologies Inc, Vertex Pharmaceuticals Inc and Theravance Biopharma Inc

Performance

Overall performance
2.9
Performance over holding periods
2.9
30 days 90 days 120 days
Average return 1% 8.2% 15.1%
Success rate 94% 68% 82%
Transactions
2 50% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Chairman of the Board NanoString Technologies Inc Jan. 1, 2010 -
Independent Director Vertex Pharmaceuticals Inc May 7, 2014 -
Lead Independent Director Theravance Biopharma Inc April 1, 2014 -
Independent Director Biomarin Pharmaceutical Inc Sept. 22, 2010 - Nov. 12, 2015
Independent Chairman of the Board Biogen Inc Jan. 1, 2010 - June 22, 2014
Independent Director Innoviva Inc April 1, 2001 - June 2, 2014
Bill Young's trades of NanoString Technologies Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-05-26 2023-05-24
B Purchase
73,583 +3.0%
418.03
US$4,217,653 		73,583 +3.0% 418.03 US$4,217,653
2022-02-28 2022-02-24
PlS Planned sale
30,880 -39.9%
128.90
US$1,448,939 		30,880 -39.9% 128.90 US$1,448,939
2022-02-28 2022-02-24
PlS Planned sale
26,451 -26.5%
59.88
US$1,731,245 		26,451 -26.5% 59.88 US$1,731,245
2022-02-28 2022-02-24
PlS Planned sale
4,273 -25.5%
32.40
US$138,445 		4,273 -25.5% 32.40 US$138,445
2022-02-28 2022-02-24
PlS Planned sale
8,498 -33.7%
31.71
US$269,472 		8,498 -33.7% 31.71 US$269,472
2022-02-28 2022-02-24
PlS Planned sale
1,716 -6.4%
30.68
US$52,647 		1,716 -6.4% 30.68 US$52,647
2022-02-28 2022-02-24
PlS Planned sale
800 -2.9%
29.66
US$23,728 		800 -2.9% 29.66 US$23,728
2004-05-26 2004-05-25
US Biogen Inc (BIIB)
S Sale
52,500 -100.0%
62.52
US$3,282,300 		52,500 -100.0% 62.52 US$3,282,300